Abstract

In chronic kidney disease, hyperphosphatemia is a key pathological factor promoting medial vascular calcification, a common complication associated with cardiovascular events and mortality. This active pathophysiological process involves osteo-/chondrogenic transdifferentiation of vascular smooth muscle cells (VSMCs) via complex intracellular mechanisms that are still incompletely understood. Little is known about the effects of phosphate on the bioenergetic profile of VSMCs during the onset of this process. Therefore, the present study explored the effects of the phosphate donor β-glycerophosphate on cellular bioenergetics of VSMCs. Mitochondrial and glycolytic functions were determined utilizing extracellular flux analysis in primary human aortic VSMCs following exposure to β-glycerophosphate. In VSMCs, β-glycerophosphate increased basal respiration, mitochondrial ATP production as well as proton leak and decreased spare respiratory capacity and coupling efficiency, but did not modify non-mitochondrial or maximal respiration. β-Glycerophosphate-treated VSMCs had higher ability to increase mitochondrial glutamine and long-chain fatty acid usage as oxidation substrates to meet their energy demand. β-Glycerophosphate did not modify glycolytic function or basal and glycolytic proton efflux rate. In contrast, β-glycerophosphate increased non-glycolytic acidification. β-Glycerophosphate-treated VSMCs had a more oxidative and less glycolytic phenotype, but a reduced ability to respond to stressed conditions via mitochondrial respiration. Moreover, compounds targeting components of mitochondrial respiration modulated β-glycerophosphate-induced oxidative stress, osteo-/chondrogenic signalling and mineralization of VSMCs. In conclusion, β-glycerophosphate modifies key parameters of mitochondrial function and cellular bioenergetics in VSMCs that may contribute to the onset of phenotypical transdifferentiation and calcification. These observations advance the understanding of the role of energy metabolism in VSMC physiology and pathophysiology of vascular calcification during hyperphosphatemia.Key messagesβ-Glycerophosphate modifies key parameters of mitochondrial respiration in VSMCs.β-Glycerophosphate induces changes in mitochondrial fuel choice in VSMCs.β-Glycerophosphate promotes a more oxidative and less glycolytic phenotype of VSMCs.β-Glycerophosphate triggers mitochondrial-dependent oxidative stress in VSMCs.Bioenergetics impact β-glycerophosphate-induced VSMC calcification.

Highlights

  • Hyperphosphatemia develops in chronic kidney disease (CKD) patients as a consequence of impaired phosphate excretion by the diseased kidneys [1, 2]

  • To investigate the early effects of phosphate exposure on the bioenergetics of vascular smooth muscle cells (VSMCs), experiments were performed in primary human aortic smooth muscle cells (HAoSMCs) treated with the phosphate donor, β-glycerophosphate [12, 14], for 24 h followed by extracellular flux analysis using the Seahorse technology to analyse parameters of mitochondrial respiration as well as glycolysis by simultaneous time course measurement of the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), respectively

  • The present study provides a detailed analysis of the bioenergetic profile of VSMCs following exposure to high phosphate conditions

Read more

Summary

Introduction

Hyperphosphatemia develops in chronic kidney disease (CKD) patients as a consequence of impaired phosphate excretion by the diseased kidneys [1, 2]. Accumulating evidence has linked metabolic changes related to mitochondrial respiratory function [20,21,22,23, 29] and glycolysis [30] with the signalling regulating osteo-/ chondrogenic transdifferentiation of VSMCs and vascular calcification Along those lines, previous studies already suggested that elevated phosphate levels promote mitochondrial dysfunction in VSMCs [21,22,23, 29] followed by oxidative stress [20, 29, 31], endoplasmic reticulum stress [32] and apoptosis [20], which mediate, at least partly, phosphate-induced vascular calcification [5]. The effects of metabolic modulators on β-glycerophosphateinduced oxidative stress, osteo-/chondrogenic transdifferentiation and calcification of VSMCs were investigated

Results
Discussion
Compliance with ethical standards

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.